ZLDPF:OTCMKTS
Zealand Pharma A/S
$35.93
arrow_upward
+1.21%(+0.43) 1D
Nov 16, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZLDPF...
Open
$35.40
High
$35.93
Low
$35.40
Mkt. cap
2.53B
Avg. vol.
449.00
Volume
280.00
52-wk high
$83.12
52-wk low
$33.08
Beta
1.25
Shares outstanding
71.61M
No. of employees
605
Open
$35.40
High
$35.93
Low
$35.40
Mkt. cap
2.53B
Avg. vol.
449.00
Volume
280.00
52-wk high
$83.12
52-wk low
$33.08
Beta
1.25
Shares outstanding
71.61M
No. of employees
605
News stories
From web sources and news partners
Benzinga
·
24 minutes ago
S&P 500 Down 1%; Disney Posts Upbeat Earnings
Barron's
·
27 minutes ago
Bear Market Watch: What the Charts Say About the S&P 500
Benzinga
·
43 minutes ago
Walmart Stock Posts Best 2-Month Run Vs. S&P 500 Since 1975 - Walmart (NASDAQ:WMT)
Traders Union
·
20 minutes ago
S&P 500 market cap falls $3 trillion over past week, Peter Tuchman notes
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees605
FoundedApr 1, 1997
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitezealandpharma.com